44. Remy JJ, Couture L, Rabesona H, et al. Immunization against exon 1 decapeptides from the lutropin/choriogonadotropin receptor
or the follitropin receptor as potential male contraceptive. J Reprod Immunol 1996;32:37-54.
45. Vickery BH, McRae GI, Goodpasture JC, et al. Use of potent LHRH analogues for chronic contraception and pregnancy termination
in dogs. J Reprod Fertil Suppl 1989;39:175-187.
46. Huirne JAF, Lambalk CB. Gonadotropin-releasing-hormone-receptor antagonists. Lancet 2001;358:1793-1803.
47. Trigg TE, Wright PJ, Armour AF, et al. Use of a GnRH analogue implant to produce reversible long-term suppression of reproductive
function in male and female domestic dogs. J Reprod Fertil Suppl 2001;57:255-261.
48. Proháczik A, Kulcsar M, Trigg T, et al. Treatments suppressing ovarian activity in ferret (Mustela putorius furo) (abst). Reprod Domest Anim 2003;38:331.
49. Inaba T, Tani H, Gonda M, et al. Induction of fertile estrus in bitches using a sustained-release formulation of a GnRH agonist
(leuprolide acetate). Theriogenology 1998;49:975-982.
50. Millar RP, Zhu YF, Chen C, et al. Progress towards the development of non-peptide orally-active gonadotropin-releasing hormone
(GnRH) antagonists: therapeutic implications. Br Med Bull 2000;56:761-772.
51. Broqua P, Riviere PJ, Conn PM, et al. Pharmacological profile of a new, potent, and long-acting gonadotrophin-releasing hormone
antagonist: degarelix. J Pharmacol Exp Ther 2002;301:95-102.
|
Featuring Information from:
